Natick

Natick is among the latest towns to have approved their own set of tobacco regulations in an effort to reduce tobacco use among youth, adding to the complex patchwork of regulations that blanket the commonwealth, according to an attorney with the Retailers Association of Massachusetts.

Convergent Dental of Natick, a privately held dental equipment and technology company, has entered into a distribution partnership for its dental laser product, Solea.

Marlborough-based medical device manufacturer Boston Scientific has reached an agreement to acquire Xlumena Inc. Based in Mountain View, Calif., Xlumena makes minimally invasive devices to drain targeted areas of the gastrointestinal tract through endoscopic ultrasound. The deal is valued at $75 million and was expected to close this week, Boston Scientific (BSX) said in a statement Wednesday afternoon.

Convergent Dental of Natick has secured $9 million in capital to help bring a dental laser product, Solea, to market.

It's been a long winter, which has delayed the start of spring – and golf – in...

Boston Scientific of Marlborough has won federal regulatory approval for an implantable medical device that helps patients at high risk for stroke, the company said.

At the end of 2005, Boston Scientific Corp. made the fateful choice to buy cardiovascular equipment company Guidant Corp. for $27 billion. Since then, repercussions from the acquisition have weighed on the Marlborough-based medical device company. But with the settlement of a lawsuit over the deal in February, the company seems to be moving forward.

Health care organizations of all kinds are striving for efficiency under the looming transition to managed-care systems.Instead of being paid for each service, providers will instead be paid to deliver care for a set number of patients annually. Naturally, this is leading providers to reconsider how they manage those patients from the moment they walk through the door.

Bing Yeo has years of experience owning and running franchises, and helping other business owners run their companies more effectively. He also isn't afraid to try new things.

Boston Scientific has agreed to pay rival Johnson & Johnson $600 million as part of a settlement of a lawsuit stemming from Boston Scientific's acquisition of Guidant Corp. nine years ago, the Marlborough life sciences company announced Tuesday. In the lawsuit, Johnson & Johnson alleged that Guidant broke a deal it had with Johnson & Johnson to merge with that firm, and sought $7.2 billion in damages. Guidant disputed the allegations. As part of the settlement, BSX said Johnson & Johnson has agreed to dismiss its lawsuit without acknowledgment of liability by Guidant. Also, BSX has agreed not to bring patent infringement or other claims related to three of Johnson & Johnson's stent products, the BSX statement said.